• Please log in or register to access this feature.

SEARCH

SEARCH BY CITATION

References

  • 1
    Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 2002; 8: 193211.
  • 2
    Brown RS, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996; 12: 17881793.
  • 3
    Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 11791185.
  • 4
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Thernau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464470.
  • 5
    Emre S, Gondolesi G, Polat K, Ben-Haim M, Artis T, Fishbein TM, et al. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2001; 7: 220225.
  • 6
    Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Poplawski S, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome: experience in 300 patients. Transplantation 1991; 51: 428431.
  • 7
    Gonwa TA, Klintmalm GB, Jennings L, Goldstein R, Husberg B. The impact of pre-transplant renal function on survival following liver transplantation. Transplantation 1995; 59: 361365.
  • 8
    Fisher NC, Nightingale PG, Gunson BK, Lipking W, Neuberger SM. Chronic renal failure following liver transplantation. Transplantation 1998; 66: 5966.
  • 9
    Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End stage renal disease (ESRD) following orthotopic liver transplantation (OLTX) utilizing calcineurin based immunotherapy: risk of development and treatment. Transplantation 2001: 72: 19341939.
  • 10
    Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002; 8: 916921.
  • 11
    Sherman DS, Fish DN, Teitlelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis 2003; 41: 269278.
  • 12
    Israelite AH, Long DL, White MG, Hull AR. Measurement of glomerular filtration rate utilizing a simple subcutaneous injection of 125I-iothalamate. Kidney Int 1973; 4: 346349.
  • 13
    Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, et al. Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol 1993; 4: 11591171.
  • 14
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 15
    Nankivell BJ, Gruenewald SM, Allen RDM, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59: 16831689.
  • 16
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461470.
  • 17
    Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
  • 18
    Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920929.
  • 19
    Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Liver Transpl 2002; 8: 91109.
  • 20
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39( suppl 1): S1S266.
  • 21
    Laskow DA, Curtis JJ, Luke RG, Julian BA, Jones P, Deierhoi M, et al. Cyclosporine-induced changes in glomerular filtration rate and urea excretion. Am J Med 1990: 88: 497502.
  • 22
    Orlando R, Mussap M, Plebani M, Piccoli P, Martin SD, Floreani M, et al. Diagnostic value of plasma Cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 850858.
  • 23
    Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 8189.
  • 24
    Schuck O, Gottfriedova H, Maly J, Jabor A, Stollova M, Bruzkova I, et al. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl 2002; 8: 594599.